Top Markets
#1 Islamic Coin Islamic Coin +151.56%
#2 Black Phoenix Black Phoenix +35.83%
#3 Palladium Network Palladium Network +20.31%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.14%
#5 Akedo Akedo +16.13%
#6 Fake World Assets Fake World Assets +12.92%
#7 OpenEden OpenEden +12.68%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.64%
#9 clBTC clBTC +12.01%
#10 Arowana Arowana +11.93%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nabriva Therapeutics plc Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRV
Rang in Aktien #39979
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Aktienkurs
$0.63
Zuletzt synchronisiert: 2023-08-29
Marktkapitalisierung
$284.20K
Veränderung (1 Tag)
-21.25%
Veränderung (1 Jahr)
0.00%
Land
IE
Handel Nabriva Therapeutics plc (NBRV)

Kategorie

Healthcare
Kursverlauf für Nabriva Therapeutics plc (NBRV)
Höchster Schlusskurs: $0.72 am 2023-08-01

Niedrigster Schlusskurs: $2.65K am 2015-09-01
Kursverlauf der Aktie von Nabriva Therapeutics plc von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -62.69%
2022 -88.16%
2021 -77.92%
2020 -82.12%
2019 -3.21%
2018 -70.79%
2017 19.90%
2016 -48.03%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.09%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE